Fosun Pharma Shanghai March 2026 Securities Movement Monthly Report: Total share capital remains stable, potential issuance space exists for H-share option plan

MaticHoleFiller · 2026-04-06T21:53:16+00:00

Fosun Pharma Group in Shanghai reported securities changes as of March 31, 2026. The statutory capital is 267,042,9325 yuan, and the issued shares are consistent with the total statutory share capital. There have been no changes in A-shares and H-shares. Unexercised options and restricted stock units have not resulted in new share issuance, and the public float of H-shares meets the requirements.

MaticHoleFiller

2026-04-06 21:53:16

Abstract generation in progress

Zhongfang Net data
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. submitted a monthly report on securities changes for the period ended March 31, 2026 on April 2, 2026. The report shows that the company’s total statutory/registered share capital remained unchanged at RMB 2,670,429,325, consisting of two parts: A shares and H shares. Of these, the statutory A-share capital is RMB 2,118,488,825, corresponding to 2,118,488,825 shares with a par value of RMB 1 each; the statutory H-share capital is RMB 551,940,500, corresponding to 551,940,500 shares with a par value of RMB 1 each.

As of the end of March 2026, the company’s total issued shares outstanding (excluding treasury shares) are 2,670,429,325, consistent with the total statutory shares. Specifically, 2,118,488,825 A shares have been issued, and 551,940,500 H shares have been issued. During the month, neither the number of issued shares nor the number of treasury shares changed.

According to the company’s 2025 A-share option scheme, as of the end of March, the number of outstanding options yet to be exercised is 4,446,400. If all are exercised, up to 1,145,200 A shares may be issued. During the month, no new shares were issued as a result of exercising these options. Meanwhile, under the 2025 H-share restricted share unit scheme, as of the end of the reporting period, a total of 10,382,200 restricted share units had been granted but not yet vested, representing rights to acquire an equivalent number of H shares. During the month, this scheme also did not lead to the issuance of new shares or the transfer of treasury shares.

The company confirms that its public float in H shares satisfies the requirements of the Listing Rules, namely that it is not less than 5% of the total number of issued shares in the H-share category (excluding treasury shares). The report was submitted by Tricor Investor Services Limited, the company’s H-share share transfer and registration agent.

Abundant information and precise analysis—available on the Sina Finance App

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.